A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins

Author： Marci R.   Senn A.   Dessole S.   Chanson A.   Loumaye E.   De Grandi P.   Germond M.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.75, Iss.6, 2001-06, pp. : 1131-1135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin

By Meo F.   Ranieri D.M.   Khadum I.   Serhal P.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 630-632

Elsevier

Access to resources Recommend Favorite

Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol

By Schoolcraft W.   Schlenker T.   Gee M.   Stevens J.   Wagley L.  

Fertility and Sterility, Vol. 67, Iss. 1, 1997-01 ,pp. : 93-97

Elsevier

Access to resources Recommend Favorite

Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization

By Lisi F.   Rinaldi L.   Fishel S.   Lisi R.   Pepe G.   Picconeri M.-G.  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 1037-1038

Elsevier

Access to resources Recommend Favorite

Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization

By Bancsi L.F.J.M.M.   Huijs A.M.   den Ouden C.T.   Broekmans F.J.M.   Looman C.W.N.   Blankenstein M.A.   te Velde E.R.  

Fertility and Sterility, Vol. 73, Iss. 3, 2000-03 ,pp. : 552-557

Elsevier

Access to resources Recommend Favorite

A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment

By Yong P.Y.K.   Brett S.   Baird D.T.   Thong K.J.  

Fertility and Sterility, Vol. 79, Iss. 2, 2003-02 ,pp. : 308-315

Elsevier

Access to resources Recommend Favorite